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JNK Activation Is Not Linked to Apoptosis
While NF-kB Activation Prevents Cell Death
Zheng-gang Liu,* Hailing Hsu,†‡ David V. Goeddel,† to be transduced by TNFR1, many can also be mediated
by TNFR2 (Tartaglia and Goeddel, 1992; Smith et al.,and Michael Karin*
1994; Vandenabeele et al., 1995). TNFR2, however, is a*Department of Pharmacology
poor inducer of apoptosis.Program in Biomedical Sciences
Exposure to TNF results in activation of two transcrip-School of Medicine
tion factors, AP-1 (Brenner et al., 1989) and NF-kB (Os-University of California, San Diego
born et al., 1989). These transcription factors mediateLa Jolla, California 92093–0636
induction of other cytokine and immunoregulatory†Tularik Incorporated
genes, as well as metalloproteinases. Several secondTwo Corporate Drive
messengers have been proposed to mediate the biologi-South San Francisco, California 94080
cal effects of TNFR ligation, including various phospho-
lipid breakdown products, arachidonic acid metabolites,
free radicals, and increased intracellular Ca21 (reviewedSummary
by Beyaert and Fiers, 1994). However, as discussed by
Beyaert and Fiers, (1994), it is not clear whether theseThrough its type 1 receptor (TNFR1), the cytokine TNF
are true second messengers or secondary effects ofelicits an unusually wide range of biological re-
TNFR activation. Several protein kinases were found tosponses, including inflammation, tumor necrosis, cell
be activated rapidly in response to TNF, including yet-proliferation, differentiation, and apoptosis. We inves-
to-be-identified ceramide-activated kinase (Weigmanntigated how TNFR1 activates different effector func-
et al., 1994), IkB kinase (DiDonato et al., 1996), and ations; the protein kinase JNK, transcription factor NF-
TNFR1-associated serine/threonine kinase (VanArsdale
kB, and apoptosis. We found that the three responses
and Ware, 1994), as well as the molecularly identifiedare mediated through separate pathways. Recruit-
Raf-1 (Belka et al., 1995), Jun N-terminal kinases (JNKs;ment of the signal transducer FADD to the TNFR1
Minden et al., 1994), and p38/Mpk2 (Raingeaud et al.,complex mediates apoptosis but not NF-kB or JNK
1995). Activation of the IkB kinase results in NF-kB acti-activation. Two other signal transducers, RIP and
vation (Verma et al., 1995; DiDonato et al., 1996), whileTRAF2, mediate both JNK and NF-kB activation. These
Raf-1, JNK, and p38/Mpk2 activation contribute to in-two responses, however, diverge downstream to
duction of AP-1 activity (Karin, 1995). The pathways byTRAF2. Most importantly, JNK activation is not in-
which TNFR ligation causes activation of these proteinvolved in induction of apoptosis, while activation of
kinases are not clear. Recently, much emphasis has
NF-kB protects against TNF-induced apoptosis.
been placed on the potential role of ceramide as a medi-
ator of TNF signaling. TNF-induced phospholipid hydro-
Introduction lysis can result in ceramide production (Kolesnick and
Golde, 1994), and exogenous ceramide can lead to acti-
Tumor necrosis factor (TNF) is a cytokine produced by vation of NF-kB (Weigmann et al., 1994) and JNK (Verheij
many cell types, including macrophages, monocytes, et al., 1996) and apoptosis (Obeid et al., 1993). However,
lymphoid cells, and fibroblasts, in response to inflamma- it is also possible that ceramide is produced as a result
tion, infection, and other environmental challenges (Tra- of TNF-induced cell death (Beyaert and Fiers, 1994).
cey and Cerami, 1993). TNF elicits a wide spectrum A major advance in understanding early events in TNF
of organismal and cellular responses, including fever, signaling was the identification of protein molecules that
shock, tissue injury, tumor necrosis, anorexia, induction are recruited to TNFR1 and TNFR2, following ligand in-
of other cytokines and immunoregulatory molecules, duced trimerization (Rothe et al., 1994, 1995a; Hsu et al.,
cell proliferation, differentiation, and apoptosis (Tracey 1995). While activation of TNFR1 results in recruitment of
and Cerami, 1993; Vandenabeele et al., 1995). These the TNFR1-associated death domain protein (TRADD;
responses are elicited by TNF-induced trimerization of Hsu et al., 1995, 1996a), occupancy of TNFR2 leads
two distinct cell surface receptors, TNFR1 (p55) and to recruitment of TNFR-associated proteins 1 and 2
TNFR2 (p75), at least one of which is present in almost (TRAF1 and TRAF2; Rothe et al., 1994), as well as c-IAP1
every cell type (Tartaglia and Goeddel, 1992; Smith et and c-IAP2 (Rothe et al., 1995a). Recently TRADD was
al., 1994; Vandenabeele et al., 1995). The structural simi- shown to interact directly with two otherproteins, TRAF2
larity between the two TNF receptors is limited to their and Fas-associated protein with death domain (FADD;
extracellular domains (Tartaglia and Goeddel, 1992). The Hsu et al., 1996a). The recruitment of TRAF2 to both
TNFR ectodomains are related to those of CD30, CD40, TNFR1 and TNFR2 explains why both receptors can
CD27, and Fas, all of which belong to the TNF receptor elicit certain overlapping responses, despite having dif-
superfamily (Smith et al., 1994). The ligands for these ferent cytoplasmic domains. Indeed, TRAF2 appears to
receptors are structurally related to TNF, and many of mediate NF-kB activation by both TNFR1 and TNFR2,
them are cell-surface anchored (Smith et al., 1994). Al- as well as by the related CD40 receptor (Rothe et al.,
though most of the biological activities of TNF appear 1995b; Hsu et al., 1996a). FADD (also known as MORT1)
was originally identified as a protein that interacts with
the cytoplasmic domain of Fas (Boldin et al., 1995; Chin-‡ Present Address: Amgen, 1840 Dehavilland Drive, Thousand Oaks,
California 91320 naiyan et al., 1995), which is structurally related to the
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cytoplasmic domain of TNFR1 (Itoh and Nagata, 1993;
Tartaglia et al., 1993a). The death domain present in
the cytoplasmic portions of both receptors mediates
protein–protein interactions with other death domain–
containing proteins, such as TRADD (Hsu et al., 1995)
and FADD (Boldin et al., 1995; Chinnaiyan et al., 1995).
Another death domain protein is the serine/threonine
kinase RIP (for receptor-interacting protein; Stanger et
al., 1995; Hsu et al., 1996b). Originally identified by its
interaction with Fas (Stanger et al., 1995), RIP was re-
cently shown to be recruited to the TNFR1 signaling
complex via TRADD and to participate in NF-kB activa-
tion (Hsu et al., 1996b). The use of dominant-negative
mutants suggests that TRADD is required for induction
of apoptosis by TNFR1 (Hsu et al., 1996a, 1996b) and
expression of both TRADD and RIP death domains is
sufficient to activate this process (Hsu et al., 1995,
1996b; Stanger et al., 1995). Apoptosis induction by
TNFR1 also appears to require FADD, but unlike TRADD
and RIP, this activity is mediated by the FADDN-terminal
domain rather than its death domain (Chinnaiyan et al.,
1995; Hsu et al., 1996a). In fact, the FADD death domain
blocks TNF-induced apoptosis (Hsu et al., 1996a; Chin-
naiyan et al., 1996). The N-terminal death effector do-
main of FADD interacts with the ICE-like protease MACH
(for MORT1-associating CED homolog) or FLICE (for
FADD-like interleukin-1b-converting enzyme [ICE]),
which appears to be a direct activator of the apoptotic
protease cascade (Boldinet al.,1996; Muzio et al., 1996).
These results suggest the protein-recruitment model for
TNFR1 signaling that is illustrated in Figure 1. TNF-
induced trimerization of TNFR1 results in recruitment Figure 1. The Protein Recruitment Model for TNFR1 Signaling
of TRADD and RIP via death domain interactions. The (A) Ligand-induced trimerization of TNFR1 results in recruitment of
TNFR1–TRADD complex then recruits at least three TRADD to the cytoplasmic domain of the receptor via death domain
other signaling proteins: RIP, FADD, and TRAF2. While (closed boxes) interactions. TRADD serves as a platform for recruit-
ment of two additional death domain proteins, RIP and FADD, andFADD activates the apoptotic machinery, TRAF2 and
for recruitment of TRAF2, which does not contain a death domain.RIP mediate NF-kB activation.
The latter interaction is mediated by the N-terminal domain ofThese results, however, provide no clue to the mecha-
TRADD and the C-terminal TRAF-C domain of TRAF2 (hatched box).nism by which TNFR1 can activate the JNK and p38
While FADD signals to the apoptotic protease cascade, TRAF2 and
mitogen-activated protein kinase (MAPK) cascades or RIP mediate NF-kB activation.
stimulate AP-1 activity. Furthermore, it was recently sug- (B) The salient features of TRADD, FADD, RIP, and TRAF2. The
gested that JNK and its target c-Jun are critical media- protein domains and the targets with which they interact are indi-
cated. Closed boxes, death domain. The different hatched boxestors of apoptosis induced by TNF or ceramide (Verheij
denote the RIP N-terminal kinase domain, the N-terminal ring fingeret al., 1996). It is not clear how these results relate to
of TRAF2, and its C-terminal TRAF domain.the protein-recruitment model for TNFR1 and Fas signal-
ing. In addition, Fas ligation results in only modest and
of apoptosis. Although both JNK and NF-kB are acti-delayed JNK activation (Z. G. L., unpublished data; Len-
vated via TRAF2 and RIP, we were able to dissociateczowski et al., 1996), while CD40 ligation, which protects
these responses as well. We also found that inhibitionB cells against apoptosis (Liu et al., 1989; Tsubata et
of NF-kB activation, but not JNK, greatly increases theal., 1993), causes potent JNK activation (Berberich et
sensitivity of HeLa cells to TNF- induced apoptosis. Byal., 1996). There is also a considerable degree in overlap
contrast, deliberate NF-kB activation protects againstbetween the type of signals that activate NF-kB (Verma
TNF-induced apoptosis. Thus, ligation of TNFR1 resultset al., 1995) and those that activate JNK and p38
in activation of at least three distinct effector functions,(Raingeaud et al., 1995).
which can explain its ability to induce a plethora ofTo determine the relationship between JNK activation
diverse biological responses. These results can alsoin response to TNFR1 ligation, activation of NF-kB, and
explain why other members of the TNF receptor familyinduction of apoptosis, we examined the ability of indi-
can only affect subsets of these responses.vidual components of the TNFR1 signaling complex to
activate these responses. In addition, we tested the abil-
Resultsity of various dominant-negative mutants to interfere
with JNK and NF-kB activation and induction of apop-
tosis. We found that TRAF2 and RIP but not FADD are Activation of JNK by Components of TNFR1
Signaling Complexthe critical intermediates in JNK activation. Furthermore,
we show that dominant negative TRAF2 and FADD mu- The protein recruitment model, for TNF signaling is illus-
trated in Figure 1A. According to this model, TNF-tants clearly dissociate JNK activation from induction
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induced trimerization of TNFR1 results in the recruitment
of TRADD, which serves as a platform for recruitments
of at least three additional proteins, FADD, RIP, and
TRAF2 (Hsu et al., 1996a, 1996b). While both FADD and
RIP contain death domains, which interact with the
death domain of TRADD, TRAF2 uses its TRAF domain
to interact with the N-terminal region of TRADD and the
intermediate domain of RIP (Hsu et al., 1996b). Owing
to the presence of a common TRAF domain, TRAF1
(Rothe et al., 1994) and TRAF3 (Hu et al., 1994) may also
be recruited to TRADD and RIP signaling complexes
(Hsu et al., 1996a, 1996b). The salient features of the
different components of the TNFR1 signaling complex
are shown in Figure 1B.
We examined the ability of these proteins to activate
JNK ina cotransfection assay (Minden et al., 1994, 1995).
Different expression vectors were cotransfected with
a hemagglutinin (HA) epitope–tagged JNK1 vector into
MCF7 cells, and their respective effects on HA–JNK1
expression and activity were determined 24 hr later by
immunoblots and immune complex kinase assays. Ow-
ingto theability of thedeath domain–containing proteins
TRADD, FADD, and RIP to induce apoptosis (Hsu et al.,
1996a, 1996b; Stanger et al., 1995; Chinnaiyan et al.,
1995), their expression resulted in a considerable de-
crease in the amount of HA–JNK1 expression (Figures
2A and 2C). Therefore, we examined their effect on HA–
JNK1 activity in the presence of the cowpox virus
apoptosis inhibitor CrmA (Ray et al., 1992; Enari et al.,
1995; Tewari and Dixit, 1995). The only components of
the TNFR1 complex capable of stimulating JNK activity
Figure 2. Activation of JNK by Components of the TNFR1 Signalingas efficiently as TNF were TRAF2 and RIP. Interestingly,
ComplexTRADD, which activates apoptosis or NF-kB very effi-
(A) MCF7 cells were cotransfected with an HA-JNK1 vector (0.5 mgciently (Hsu et al., 1996a; see below), had only a marginal
per plate) and either an empty expression vector or expressioneffect on JNK activity (Figures 2A and 2C). None of the
vectors encoding the indicated components of the TNFR1 signaling
TNFR1 components was capable of stimulating ERK2 complex, or fragments thereof (1 mg of each plasmid). When indi-
(for extracellular signal–regulated protein kinase) activ- cated, a CrmA expression vector (0.5 mg per plate) was also in-
ity in MCF7 cells (Figure 2B). Similar results were ob- cluded. Total amount of DNA was kept constant (2.0 mg per plate) by
using empty expression vector. After 24 hr some of the transfectedtained with all of the TNFR1 components in HeLa and
cultures were treated with TNF (15 ng/ml) for 30 min, as indicated,293 cells (data not shown). Both HeLa and MCF7 cells
and the rest left untreated. The cells were collected and lysed, andexpress TNFR1 and no or very low amounts of TNFR2
HA–JNK1 activity was determined by immunecomplex kinase assay
(Tartaglia et al., 1993b; H. H. and D. V. G., unpublished with GST–c-Jun(1–79) as a substrate. The level of HA–JNK1 expres-
data). We also found that TRAF2 and RIP, but not the sion was determined by immunoblotting with a JNK1 monoclonal
other proteins, were efficient p38 activators (data not antibody. The fold increase in HA–JNK1 activity above the basal
level in cells cotransfected with empty expression vector was deter-shown).
mined by phosphoimaging and normalized to the level of HA–JNK1We examined whether the death domain or the kinase
expression. Similar results were obtained in at least three differentdomain of RIP are required for JNK activation. We found
experiments.
that RIP(1–558), which lacks the death domain and (B) MCF7 cells were transfected as described above except that an
therefore is incapable of triggering apoptosis (Hsu et HA–ERK2 vector (0.5 mg) was used instead of the HA–JNK1 vector.
al., 1996b), was even more efficient than wild-type RIP ERK2 activity was determined by immunecomplex kinase assaywith
myelin basic protein (MBP) as a substrate.in activating JNK (Figure 3). A kinase-defective RIP
(C) MCF7 cells were cotransfected as described in (A) with HA–JNK1(K45A) mutant was somewhat less active but was still
and either an empty expression vector (1.0 or 1.5 mg per plate) orcapable of JNK activation.The kinase-defective RIPwas
RIP, TRADD, or FADD vectors (1.0 mg per plate). A CrmA vector (0.5
expressed as efficiently as wild-type RIP, while the trun-
mg per plate) was included where indicated. After 24 hr, the cells
cated RIP(1–558) was expressed more efficiently. These were treated with TNF, when indicated, or left untreated. After 30
results dissociate the apoptotic activity of RIP, which min, the cells were collected and HA–JNK1 activity and expression
were determined as described above.requires its death domain, from its ability to acti-
vate JNK.
mutant lacking the ring finger, or RIP(559–671), which
consists only of the death domain, can prevent JNKTNF-Induced JNK Activation Requires
TRAF2 and RIP activation by TNF. As both of these mutants are capable
of binding to TRADD and inhibition of NF-kB activation,To examine whether TRAF2 and RIP are required for
JNK activation, we tested whether TRAF2(87–501), a they probably compete for theendogenous components
Cell
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Figure 3. The Death Domain and the Kinase Activity of RIP Are Not
Essential for JNK Activation
MCF7 cells were transfected with HA–JNK1 vector (0.5 mg per plate)
and either empty expression vector or myc–RIP, myc–RIP(1–558),
or myc–RIP(K45A) expression vectors (1 mg each). CrmA expression
vector was included where indicated. After 24 hr, some of the cells
were treated with TNF for 30 min and the rest left untreated. HA–
JNK1 activity and expression were determined as described above.
A sample of the transfected cell lysates was also used to determine
the expression of RIP proteins by immunoblotting with Myc antibody
(9E10, Pharmingen).
of the TNFR1 signaling complex (Hsu et al., 1996a, Figure 4. JNK Activation by TNF Is Blocked by the TRAF2(87–501)
1996b). We foundthat bothTRAF2(87–501) and RIP(559– and RIP(559–671) Dominant Negative Mutants
671) also inhibited JNK activation by TNF (Figure 4A). (A) MCF7 cells were cotransfected with HA–JNK1, TRAF3(87–501),
The RIP(559–671) mutant had to be coexpressed with FADD(80–205), RIP(559–671), and CrmA expression vectors, as indi-
cated. After 24 hr, half of the transfected cultures were treated withCrmA because it is a potent inducer of apoptosis,
TNF for 30 min and the other half left untreated. The cells werethereby preventing the recovery of transiently expressed
collected, and HA–JNK1 expression and activity were determined,HA–JNK. We also found that a FADD(80–205) mutant,
as described in the legend to Figure 2.
which completely blocks TNF-induced apoptosis (Chin- (B) MCF7 cells were cotransfected with HA–JNK1 together with
naiyan et al., 1996; Hsu et al., 1996a), had no effect on either empty expression vector, TRAF2(87–501), or RIP(559–671)
JNK activation (Figure 4A). These results, the ability of expression vectors. A portion of the transfected cultures were
treated with TNF (15 ng/ml) or IL-1 (4 ng/ml) and a portion leftRIP(559–671) to induce apoptosis, and the inability of
untreated. After 30 min, the cells were collected, and HA–JNK1TRAF2(87–501) to block TNF-induced apoptosis (Hsu
activity and expression were determined.et al., 1996a, 1996b) strongly argue that the different
dominant-negative mutants act specifically by replacing
the endogenous wild-type proteins rather than by dis- inhibited by TRAF2(87–501), which did not inhibit TNF-
rupting the entire TNFR1 signaling complex. Further evi- mediated apoptosis. Instead, TRAF2(87–501) enhanced
dence for the specificity of the inhibitory activity of these the apoptotic response to TNF. Expression of FADD
mutants is provided by the inability of TRAF2(87–501) induced apoptosis even in the absence of TNF, but was
or RIP(559–671) to inhibit JNK activation by interleu- insufficient for JNK or NF-kB activation. JNK activation
kin-1 (IL-1) (Figure 4B). by either TNF or TRAF2 was inhibited by coexpression
of catalytically inactive MEKK1(K432M), which did not
prevent NF-kB activation or TNF-induced apoptosis.Activation of JNK, NF-kB, and Apoptosis
Are Separate Signaling Responses The approximate 2-fold decrease in the number of
b-galactosidase expressing cells in response to MEKK1We compared the effects of the different components
of the TNFR1 complex as well as the other regulatory (K432M) expression was due to either a reduction in
transfection efficiency or, more likely, a reduction in lacZproteins (MEKK1 [for MAPK/ERK kinase kinase 1] and
IkBa) on activation of JNK, NF-kB, and apoptosis. As expression, but was not due to induction of apoptosis.
In the absence of TNF, none of the lacZr- and MEKK1shown in Figure 5, all three responses were activated
by TNF in MCF7 cells. While TNF-induced cell death (K432M)-cotransfected cells had an apoptotic morphol-
ogy (data not shown, but see Figure 7). Induction of NF-was blocked by transfection of FADD(80–205), this mu-
tant did not inhibit either JNK or NF-kB activation. Both kB activity was specifically blocked by coexpression
of the phosphorylation-defective IkBa(A32/36) mutantJNK and NF-kB activities were stimulated by TRAF2
expression in the absence of TNF, although TRAF2 by (DiDonato et al., 1996), which had no effect on JNK
activation (Figure 5). The dominant negative IkBa(A32/itself did not induce the apoptotic response. Corre-
spondingly, both JNK and NF-kB activation by TNF were 36) did not block the apoptotic response to TNF. On the
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contrary, it seemed to enhance the induction of cell
death. These results indicate that activation of JNK, NF-
kB, and apoptosis are three separate responses to TNF.
NF-kB Activation Inhibits TNF-Induced Apoptosis
Similar results were obtained in HeLa cells (Figure 6).
In HeLa cells, however, as in many other tumor cells,
induction of apoptosis by TNF requires inhibition of on-
going protein synthesis (Beyaert and Fiers, 1994). Nei-
ther TNF nor cycloheximide alone induced considerable
cell death, but when the were combined, an intensive
apoptotic response was observed (Figure 6C). Cyclo-
heximide and several other protein synthesis inhibitors
can stimulate JNK activity (Kallunki et al., 1994; Kyriakis
et al., 1994). Indeed, cycloheximide treatment resulted
in modest JNK activation and potentiated its activation
by TNF (Figure 6A). As cycloheximide was added simul-
taneously with TNF, we could not assess its effect on
NF-kB activation, because it presumably prevented the
translation of the newly induced luciferase mRNA pro-
duced by the NF-kB reporter (Figure 6B). However, NF-
kB activation is independent of new protein synthesis
(Auphan et al., 1995).
As described above, coexpression of either TRAF2
(87–501) or IkBa(A32/36) potentiated the apoptotic re-
sponse to TNF in MCF7 cells. This effect was even more
dramatic in HeLa cells, where both mutants enabled TNF
to induce apoptosis in the absence of cycloheximide
(Figure 6C). Some of the raw results of the b-galactosi-
dase expression assay are shown in Figure 7A. Whereas
cells cotransfected with pCMVlacZ and either TRAF2
(87–501) (shown in [e]) or IkBa(A32/36) (shown in [g])
had normal appearance when incubated in standard
growth medium, the majority of these cotransfected
cells assumed a characteristic apoptotic appearance,
being round and condensed, when incubated in the
Figure 5. JNK and NF-kB Activation and Induction of Apoptosis by
TNFa Are Regulated through Distinct Pathways in MCF7 Cells
(A) JNK activation. MCF7 cells were cotransfected with HA–JNK1
and either an empty expression vector or the different expression
vectors indicated in the figure. Where indicated, the cells were
treated with 15 ng/ml TNFa for 30 min at 24 hr, after transfection.
HA–JNK1 activity and its expression level were determined as de-
scribed above. The fold increase in JNK activity was normalized
to its expression level. The data presented are averages of three
individual experiments.
(B) NF-kB activation. MCF7 cells were cotransfected with 2xNF-kB
LUC reporter (1 mg per plate), pCMVlacZ reporter (0.2 mg per plate),
and either empty expression vector or the expression vectors indi-
cated in the figure (1 mg each, total amount of DNA per plate 2.2
mg). Where indicated, cells were incubated for 12 hr with TNF at 12
hr posttransfection. Luciferase activity was measured and normal-
ized to the level of b-galactosidase activity. The results shown are
averages of three separate experiments done in duplicates.
(C) Induction of apoptosis. MCF7 cells were cotransfected with
pCMVlacZ vector (0.5 mg per plate) and either empty expression
vector or the different expression vectors indicated in the figures
(1.5 mg per plate each). Half of the transfected cultures were treated
with TNFa (15 ng/ml) at 12 hr after transfection and the other half
left untreated. All the cells were fixed and stained at 24 hr after
transfection. The number of blue cells in each transfection experi-
ment was determined by counting five different randomly chosen
fields. The results presented are averages of three individual trans-
fection experiments.
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presence of TNF (shown in [f ] and [h]). Cells transfected
with empty expression vector and treated with TNF
alone (shown in [b]) did not exhibit this morphology. In
addition to morphological changes, the apoptotic re-
sponse was associated with a marked decrease in total
b-galactosidase-positive cell number, because most of
the rounded and condensed cells have detached from
the plate. These results strongly suggest that NF-kB
activation protects HeLa cells against TNF-induced
apoptosis.
To examine whether deliberate NF-kB activation does
indeed protect against TNF-induced apoptosis, we co-
transfected HeLa cells with the pCMVlacZ reporter and
expression vectors for the NF-kB subunits p50, p65
(RelA), or c-Rel. After 24 hr, the cells were incubated
with cycloheximide with or without TNF for 12 hr, and
then the number of blue cells and their morphology were
determined. As shown in Figure 7B, transfection of the
c-Rel expression vector resulted in almost complete
inhibition of TNF-induced apoptosis, while p65 expres-
sion resulted only in partial protection. Expression of
p50 did not produce a considerable protective effect. In
reporter activation assays, the c-Rel and p65 expression
vectors led to similar degrees of transcriptional activa-
tion (17- and 13-fold, respectively), whereas by itself,
the p50 vector did not produce considerable activation
(data not shown). Microscopic examination of the cells
clearly indicated that the c-Rel- and lacZ-cotransfected
cells were resistant to TNF-induced apoptosis, while the
surrounding nontransfected cells were all dead (Fig-
ure 7C).
Discussion
JNK Activation Is Not Involved
in TNF-Induced Apoptosis
Two different mechanisms have been proposed to ex-
plain how occupancy of TNFR1 and Fas results in
apoptosis and other downstream responses. TNFR1
and Fas are unique among the TNF receptor family in
Figure 6. Activation of JNK, NF-kB, and Apoptosis by TNF Is Medi-
ated by Separate Signaling Pathways in HeLa Cells
(A) JNK activation. HeLa cells were cotransfected with HA–JNK1
and the different expression vectors, as described above for MCF7
cells. When indicated, the cells were treated with TNF (15 ng/ml),
cycloheximide (CHX, 10 mg/ml), or a combination of the two for 30
min at 24 hr posttransfection. HA–JNK1 expression and activity were
determined as described above. The results are averages of three
separate experiments.
(B) NF-kB activation. HeLa cells were cotransfected with 2xNF-kB-
LUC reporter and the different expression vectors indicated in the
figure. After 12 hr, some of the cultures were incubated for an addi-
tional 12 hr with TNF or cycloheximide, as indicated, before collec-
tion and determination of luciferase activity. The results shown are
averages of three separate experiments done in duplicate.
(C) Induction of apoptosis. HeLa cells were cotransfected with
pCMVlacZ reporter and the different expression vectors indicated
in the figure. After an additional 12 hr, half of the cultures were
treated with TNF, while the other half were left untreated. Where
indicated, cycloheximide was added also at 12 hr posttransfection.
At 24 hr posttransfection, the cells were stained with X-Gal, and the
numbers of blue cells in five randomly chosen fields were deter-
mined. The data presented represent averages of three separate
transfection experiments.
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Figure 7. Activation of NF-kB Protects against TNF-Induced Apoptosis
(A) Inhibition of NF-kB sensitizes HeLa cells to TNF. HeLa cells were transfected with pCMVlacZ reporter and either empty (a and b),
MEKK1(K432M) (c and d), TRAF2 (87–501) (e and f) or IkBa(A32/36) (g and h) expression vectors. After 12 hr, half of the cultures were treated
with TNFa (15 ng/ml) (b, d, f, and h), and the other half were left untreated (a, c, e, and g). After 12 more hr, the cells were fixed and stained
with X-Gal. The arrows indicate cells with apoptotic morphology. These results are representative of three separate experiments summarized
above.
(B) Deliberate NF-kB activation protects against TNF-induced apoptosis. HeLa cells were transfected with pCMVlacZ and either an empty
expression vector or expression vectors for the p50, p65, or c-Rel subunits of NF-kB (1 mg of DNA per plate). After 24 hr, the cells were
incubated with cycloheximide (10 mg/ml) in the absence or presence of TNFa (15 ng/ml). After 12 hr, the cells were stained with X-Gal and
counted. The number of blue cells in five randomly chosen fields was determined, and the data shown are averages of three separate
experiments.
(C) Results of a representative NF-kB protection experiment. HeLa cells were transfected with either an empty or a c-Rel expression vector,
incubated with cycloheximide (10 mg/ml) in the absence (2) or presence (1) of TNFa (15 ng/ml), and stained with X-Gal. While all of the
b-galactosidase-expressing cells transfected with empty expression vector are apoptotic, most of the b-galactosidase expressing cells
cotransfected with c-Rel expression vector are viable, but the surrounding cells are dead.
having cytoplasmic death domains (Tartaglia et al., et al., 1996). This appears to be the critical step in activa-
tion of the proapoptotic protease cascade (Chinnaiyan1993a; Itoh and Nagata, 1993). Correspondingly, most
other family members function in costimulation of im- et al., 1995). We refer to this mechanism as the protein-
recruitment model.mune responses rather than induction of apoptosis
(Smith et al., 1994). Some of them, such as CD40, even Other mechanisms proposed to explain TNFR- and
Fas-mediated signaling are based on second messen-enhance cell survival and protect against apoptosis (Liu
et al., 1989; Tsubata et al., 1993). Being protein–protein ger production (reviewed by Beyaert and Fiers, 1994;
Nagata and Golstein, 1995). Currently the most favoredinteraction domains, the death domains of TNFR1 and
Fas recruit the other death domain–containing proteins candidate for such a role is ceramide (Kolesnick and
Golde, 1994). Occupancy of either TNFR1 or Fas wasTRADD, FADD, and RIP to the trimerized receptors (Hsu
et al., 1995, 1996a, 1996b; Chinnaiyan et al., 1995; Boldin reported to result in activation of sphingomyelinases,
phospholipases that act on sphingomyelin to releaseet al., 1995; Stanger et al., 1995). In addition to its death
domain, FADD has a death-effector N-terminal domain, the lipid mediator ceramide (Weigmann et al., 1994; Gul-
bins et al., 1995). When applied exogenously, ceramidewhich recruits the ICE-like protease MACH/FLICE to
activated receptor complexes (Boldin et al., 1996; Muzio can cause apoptosis (Obeid et al., 1993) and NF-kB
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(Wiegmann et al., 1994) and JNK (Verheij et al., 1996) apoptosis by TNF does not depend on nuclear events.
Therefore, the protection conferred by the N-terminallyactivation by yet-to-be-identified mechanisms. JNK ac-
tivation was, in fact, proposed to mediate apoptosis in truncated c-Jun is likely to be mediated through a non-
specific side effect. Curiously, the N-terminally trun-response to either TNF or exogenous ceramide via a
c-Jun dependent mechanism (Verheij et al., 1996). How- cated c-Jun also protected cells against a very high
dose of UV-C (Verheij et al., 1996), which is capableever, c-Jun is a nuclear protein and a transcription factor
(Angel and Karin, 1991), while TNF and Fas ligand induce of reducing cell viability by 2–3 orders of magnitude
(unpublished data). By contrast, previous work usingapoptosis without new protein or RNA synthesis and
can do so even in the absence of a nucleus (Nagata and both HeLa cells (Devary et al., 1992) and yeast (Engel-
berg et al., 1994), suggested that the eukaryotic UVGolstein, 1995). It is therefore difficult to understand
how c-Jun induction and phosphorylation can mediate response involving AP-1 activation is a protective re-
sponse. This hypothesis is strongly supported by recentapoptosis by these factors. To solve this problem, we
investigated which components of the TNFR1 signaling results obtained using c-jun-null mouse fibroblasts (F.
Piu and M. K., unpublished data; E. Wagner, personalcomplex lead to JNK activation.
The only two components of the TNFR1 complex communication). It is likely that the correlation between
ceramide production, JNK activation, and apoptosis iswhose transient expression results in JNK activation
are TRAF2 and RIP (Figure 2). While TRAF2 does not caused by a secondary and delayed effect of TNFR1
or Fas activation. For example, the cell death processmediate apoptosis (Hsu et al., 1996a; Figures 5 and
6), RIP does (Stanger et al., 1995; Hsu et al., 1996b). probably results in activation of sphingomyelinases and
otherphospholipases that mediate degradation of mem-However, a RIP deletion mutant that lacks the death
domain and therefore is incapable of inducing apoptosis branes. Indeed, it was recently shown that inhibitors
of ICE proteases can block the slow and modest JNK(Hsu et al., 1996b) is fully competent in activation JNK
(Figure 3). Furthermore, expression of the RIP death activation caused by Fas ligation (Lenczowski et al.,
1996). In addition, inhibition of ICE-like proteases wasdomain (RIP(559–641)), which is sufficient for induction
of apoptosis (Stanger et al., 1995; Hsu et al., 1996b), shown to block ceramide production by Drosophila mel-
anogaster tissue culture cells expressing the death do-does not activate JNK. Rather, RIP(559–671) blocks JNK
activation by TNF, but not by the nonrelated cytokine main protein REAPER (Pronk et al., 1996).
IL-1 (Figure 4). Thus, although RIP is capable of both
JNK activation and induction of apoptosis, the two re- The Relationship between JNK and NF-kB
Both JNK and p38 are activated by a spectrum of stimulisponses can be separated and involve different func-
tional domains of this protein. Further evidence that JNK similar to those that cause NF-kB activation (Raingeaud
et al., 1995; Verma et al., 1995). It was reported thatactivation and induction of apoptosis are two separate
downstream responses to TNF is provided by the find- transient MEKK1 expression can lead to NF-kB activa-
tion and that JNK can associate with c-Rel (Meyer etings that the FADD(80–205) death domain blocked TNF-
induced apoptosis but not JNK activation, while wild- al.,1996). Our results, however, showthat although there
are certain similarities between NF-kB and JNK activa-type FADD induced apoptosis but not JNK activity;
that the catalytically inactive MEKK1(K432M) mutant tion by TNF, these two responses are distinct. Both NF-
kB (Hsu et al., 1996a; Rothe et al., 1995b) and JNKblocked JNK activation but not apoptosis; and that
TRAF2(87–501) inhibited JNK activation while potentiat- (Figure 2) are activated by transiently expressed TRAF2
or RIP. In addition, their activation by TNF is blockeding the apoptotic response (Figures 5 and 6).
In addition to ruling out the involvement of JNK in by expression of TRAF2(87–501) or by the RIP death
domain (residues 559–771). However, NF-kB activity isTNF-induced apoptosis, these results are consistent
with other observations. Like TNFR1, ligation of CD40 potently stimulated by transient TRADD expression (in
the presence of CrmA; Hsu et al., 1995), which has onlycauses robust JNK activation (Berberich et al., 1996),
but unlike TNFR1, CD40 is not a direct mediator of a marginal effect on JNK activity (Figure 2). Furthermore,
TNF-mediated JNK activation is blocked by MEKK1apoptosis, and its activation prevents apoptosis in B
cells (Smith et al., 1994; Liu et al., 1989; Tsubata et al., (K432M), which has no effect on NF-kB activation. Thus,
the NF-kB and JNK pathways are two distinct effectors1993). Another potent JNK activator is IL-1, which, like
TNF, is also a poor activator of the ERK group of MAPKs of TNF signaling. As JNK and NF-kB activation are both
mediated by RIP and TRAF2, it is not obvious which of(Raingeaud et al., 1995). Unlike TNF or Fas ligand, IL-1
does not induce apoptosis (Tracey and Cerami, 1993). these two signaling proteins is the most downstream
mediator. However, on the basis of the ability of CD40On the other hand, Fas ligation, which is even more
effective than TNFR1 in inducing apoptosis (Nagata and to elicit potent NF-kB (Rothe et al., 1995b) and JNK
(Berberich et al., 1996) activation, it is likely that TRAF2Golstein, 1995), leads to modest and slow JNK activa-
is the more downstream and critical mediator of JNKtion, which appears to be secondary to activation of the
and NF-kB activation (Figure 8). As CD40 lacks a deathapoptotic protease cascade (Lenczowski et al., 1996).
domain and is unable to trigger apoptosis (Smith et al.,Our findings, however, are inconsistent with the pro-
1994), the CD40 signaling complex is unlikely to includeposal that JNK activation and c-Jun are critical media-
proteins such as RIP.tors of apoptosis in response to TNF (Verheij et al., 1996;
Cuvillier et al., 1996). These proposals are based on
the ability of ceramide to activate JNK and catalytically The Relationship between NF-kB
and Apoptosisinactive JNKK1 (SEK1) or N-terminally truncated c-Jun
to block apoptosis (Verheij et al., 1996). As mentioned Induction of apoptosis by TNF is independent of new
protein synthesis. On the contrary, protein synthesisabove, c-Jun is a nuclear protein, while induction of
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These results are consistent with the demonstrated
ability of IL-1, another potent NF-kB activator, to protect
against TNF-induced apoptosis (Holtmann and Wallach,
1987). In addition, knockout mouse embryos deficient
in the p65(RelA) subunit of NF-kB exhibit increased
apoptosis in the liver (Beg et al., 1995). It will therefore
be of interest to determine whether inhibition of NF-kB
activation can confer sensitivity to TNF-induced apop-
tosis in normal, nontransformed cells. These results may
also explain why Fas activation, which unlike that of
TNFR1 does not lead to NF-kB activation, results in a
more efficient and rapid apoptotic response than the
one usually caused by TNFR1 activation (Nagata and
Golstein, 1995).
Conclusions
The results described above indicate that the TNFR1
signaling complex leads to activation of at least three
distinct effector functions, JNK and NF-kB activation
and induction of apoptosis (Figure 8). This multiplicity
of effector functions can explain why TNFR1 can trans-
duce an unusually large number of diverse biological
responses, while other members of the TNF reporter
family elicit only subsets of these responses and even
antagonize some of the TNFR1-mediated responses
(Smith et al., 1994). While TNF-induced apoptosis is
most likely mediated via FADD-induced MACH/FLICE
recruitment and activation of the proapoptotic protease
cascade (Boldin et al., 1996; Muzio et al., 1996), JNK
and NF-kB activation are mediated via TRAF2 and RIP
Figure 8. Summary of TNFR1-Mediated Signaling Pathways recruitment. Despite the reliance on common mediators,
TNF-induced JNK or NF-kB activation is mediated by TRAF2 and JNK and NF-kB activation are two separate responses.
RIP, while FADD induces apoptosis. The activation of NF-kB via IkB JNK activation is probably the critical step mediating
kinase protects cells from TNF-induced apoptosis. JNK activation
induction of AP-1 activity by TNF (Brenner et al., 1989;procedes via MEKK.
Karin, 1995). Together with NF-kB, AP-1 is likely to medi-
ate induction of other cytokines and immunoregulatory
inhibitors confer sensitivity to TNF in most types of TNF- molecules by TNF, leading to a variety of inflammatory
resistant tumor cells (Beyaert and Fiers, 1994). Such responses. Interestingly, both AP-1 and NF-kB activities
observations raised the possibility that in resistant cell are inhibited by glucocorticoids, which are potent anti-
types, TNF may induce synthesis of antiapoptotic pro- inflammatory agents (Auphan et al., 1995). As TRAF2 is
teins. Our results shed light on the mechanism by which also recruited to TNFR2 and CD40 (Rothe et al., 1994,
TNF may induce such apoptosis inhibitors. We observed 1995b), it is not surprising that these receptors also lead
that in HeLa cells, where TNF cannot induce apoptosis to efficient activation of NF-kB, JNK, and AP-1-mediated
by itself, the apoptotic response can be activated when responses. On the other hand, these receptors do not
either dominant-negative TRAF2(87–501) or IkBa(A32/ recruit FADD or other death domain proteins and there-
36) is expressed together with TNF treatment. While fore are unable to affect apoptosis as TNFR1 and Fas
TRAF2(87- 501) inhibits both JNK and NF-kB activation, do. By contrast, a receptor such as Fas, which recruits
IkBa(A32/36) is a specific inhibitor of NF-kB. However, FADD but not TRAF2, is unable to cause direct and
an inhibitor of JNK activation, MEKK1(K432M), which efficient JNK or NF-kB activation and therefore unable
has no effect on NF-kB, does not enhance the apoptotic to elicit inflammatory responses. As NF-kB activation
response. Furthermore, expression of the NF-kB com- can protect cells against apoptosis, the inability of Fas to
ponent c-Rel and, to a lesser extent, expression of elicit this response can explain why it is a more effective
p65(RelA) protect HeLa cells against TNF-induced apoptosis inducer than TNFR1. On the other hand, re-
apoptosis (in the presence of cycloheximide). We there- ceptors such as CD40 that activateNF-kB but areunable
fore conclude that induction of antiapoptosis genes by to recruit death domain proteins can protect cells
TNF is most likely mediated by NF-kB (Figure 8). While against apoptosis.
the NF-kB-activated antiapoptotic genes remain to be
identified, there are two likely candidates for such a role: Experimental Procedures
manganese superoxide dismutase (Wong and Goeddel,
Cell Culture and Cytokines1988) and the zinc finger protein A20 (Opipari et al.,
Human breast carcinoma MCF7 cells were cultured in RPMI 16401992). Expression of the genes encoding these proteins
medium with 10% heat-inactivated fetal bovine serum (FBS), 1 mM
is TNF inducible, and constitutive expression of each glutamate, 100 U/ml penicillin, and 100mg/ml streptomycin (Chinnai-
of them provides partial protection against apoptosis yan et al., 1995). HeLa and 293 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% FBS,(Wong et al., 1989; Opipari et al., 1992).
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1 mM glutamate, 100 U/ml penicillin, and 100 mg/ml streptomycin. (TNF)-a activates c-raf-1 kinase via the p55 TNF receptor engaging
neutral sphingomyelinase. EMBO J. 14, 1156–1165.Human recombinant TNFa and IL-1a were purchased from R & D
Systems. Berberich, I., Shu, G., Siebelt, F., Woodgett, J.R., Kyriakis, J.M.,
and Clark, E.A. (1996). Cross-linking CD40 of B cells preferentially
induces stress-activated protein kinases rather than mitogen-acti-
Expression Vectors and Transfections vated protein kinases. EMBO J. 15, 92–101.
pSRa-HA-JNK1, pSRa-HA-ERK2, pSRa-MEKK(K432M), pSRa-Ik- Beyaert, R., and Fiers, W. (1994). Molecular mechanisms of tumor
Ba(A32/36), and p2xNF-kB-LUC have been described (De´rijard et necrosis factor-induced cytotoxicity. FEBS Lett. 340, 9–16.
al., 1994; Minden et al., 1994; DiDonato et al., 1995). Expression
Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H.,vectors for TRAF1, TRAF2, TRAF3, FADD, TRADD, TRAF2(87–501),
and Wallach, D. (1995). A novel protein that interacts with the deathFADD(80–205), RIP, RIP(K45A), RIP(1–558), RIP(559–671), FADD(1–
domain of Ras/APO1 contains a sequence motif related to the death117), and CrmA have also been described (Hsu et al., 1995, 1996a,
domain. J. Biol. Chem. 270, 7795–7798.1996b; Chinnaiyan et al., 1995). Expression vectors for p50, p65,
and c-Rel have been described (Kieran et al., 1990; Ruben et al., Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996).
1992; Mercurio et al., 1993). For transfections, 2 3 105 cells in 35- Involvement of MACH, a novel MORT1/FADD-interacting protease,
mm dishes were transfected with 1.5–2.2 mg of DNA, by using in Fas/APO-1 and TNF receptor–induced cell death. Cell 85,
lipofectamine (GIBCO BRL) as described(Minden et al., 1994). Lucif- 803–815.
erase activity was determined andnormalized relative to b-galactos- Brenner, D.A., O’Hara, M., Angel, P., Chojkier, M., and Karin, M.
idase expression as described (Hsu et al., 1995). (1989). Prolonged activation of jun and collagenase genes by tumor
necrosis factor-alpha. Nature 337, 661–663.
Immunoblotting Chinnaiyan, A.M., O’Rourke, K., Tewari, M., and Dixit, V.M. (1995).
Cell lysates (30 mg of protein) were resolved by 10% SDS–PAGE FADD, a novel death domain–containing protein, interacts with the
and transferred onto Immobilon P membrane (Millipore). After death domain of Fas and initiates apoptosis. Cell 81, 505–512.
blocking with 5% milk in PBS-T (PBS with 0.05% Tween 20) for 1
Chinnaiyan, A.M., Tepper, C.G., Seldin, M.F., O’Rourke, K., Kischkel,hr, the membranes were probed with monoclonal antibodies anti-
F.C., Hellbardt, S., Krammer, P.H., Peter, M.E., and Dixit, V.M. (1996).JNK1 333.8 (Pharmingen) or anti-c-MYC 9E10 (Pharmingen) and
FADD/MORT1 is a common mediator of CD95(Fas/APO-1) and tu-visualized with enhanced chemiluminescence detection (Amersham
mor necrosis factor receptor–induced apoptosis. J. Biol. Chem. 271,International) as described (Minden et al., 1994).
4961–4965.
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Note Added in Proof
After this paper was accepted for publication, we found that Wu et
al. reported that inhibition of NF-kB/Rel activity can induce sponta-
neous apoptosis of B cells (Wu et al. [1996] EMBO J., 15, 4682–4690.
